2Marsh JW, Finkelstein SD, Schwartz ME, et al. Advancing the diagnosis and treatment of hepatoeellular carcinoma [J]. Liver Transpl, 2005, 11(4): 469-72.
3Portsmouth D, Hlavaty J, Renner M. Suicide genes for cancer therapy [J]. Mol Aspects Med, 2007, 28 (1): 4-41.
4Altaner C. Prodrug cancer gene therapy[J]. Cancer Lett, 2008, 270 (2): 191-201.
5Stefani AL, Barzon L, Castagliuolo I, et al. Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma[ J ]. Hepatol, 2005, 42(5): 728-35.
6Majumdar AS, Hughes DE, Lichtsteiner SP, et al. The telomerase reverse transeriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters [J]. Gene Ther, 2001, 8(7): 568-78.
7Bonini C, Ferrari G, Verzeletti F, et al. ADV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia [J]. Science, 1997, 276: 1719-22.
8Sterman DH, Treat J, Litzky LA, et al. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma [J]. Huanm Gene Ther, 1998,9: 1083-92.
9ZHOU JF, GAO QL, CHEN G, et al. Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and minor cell viability[J ]. Clin Cancer Res, 2005, 11 : 8431-40.
10AltanerC. Prodrug cancer gene therapy[J]. CancerLett, 2008, 270(2) ; 191-201.
